These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11905267)

  • 1. Pediatric research regulations under legal scrutiny: Grimes narrows their interpretation.
    Kopelman LM
    J Law Med Ethics; 2002; 30(1):38-49. PubMed ID: 11905267
    [No Abstract]   [Full Text] [Related]  

  • 2. In defense of the Hopkins Lead Abatement Studies.
    Ross LF
    J Law Med Ethics; 2002; 30(1):50-7. PubMed ID: 11905268
    [No Abstract]   [Full Text] [Related]  

  • 3. Whose duty is it anyway?: the Kennedy Krieger opinion and its implications for public health research.
    Hoffmann DE; Rothenberg KH
    J Health Care Law Policy; 2002; 6(1):109-47. PubMed ID: 15017954
    [No Abstract]   [Full Text] [Related]  

  • 4. U.S. investigating Johns Hopkins study of lead paint hazard.
    Lewin T
    N Y Times Web; 2001 Aug; ():A11. PubMed ID: 12155620
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk standards for pediatric research: rethinking the Grimes ruling.
    Wendler D
    Kennedy Inst Ethics J; 2004 Jun; 14(2):187-98. PubMed ID: 15281189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grimes v. Kennedy Krieger Institute, Inc.
    Maryland Court of Appeals
    Wests Atl Report; 2001; 782():807-62. PubMed ID: 15765579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parental consent for children's participation in biomedical research: the ethical, regulatory, and judicial framework of Grimes v. Kennedy Krieger Institute, Inc.
    Thiel KS
    J Health Care Law Policy; 2002; 6(1):169-93. PubMed ID: 15017956
    [No Abstract]   [Full Text] [Related]  

  • 8. Nontherapeutic research, minimal risk, and the Kennedy Krieger lead abatement study.
    Nelson RM
    IRB; 2001; 23(6):7-11. PubMed ID: 12737175
    [No Abstract]   [Full Text] [Related]  

  • 9. Balancing moral principles in federal regulations on human research.
    Ackerman TF
    IRB; 1992; 14(1):1-6. PubMed ID: 11652041
    [No Abstract]   [Full Text] [Related]  

  • 10. Maryland Court ruling sets precedent on research involving minors. Grimes v. Kennedy Krieger Institute, Inc.
    Roeder KH; Martin SH; Rees JS
    GHA Today; 2001 Oct; 45(9):3, 8. PubMed ID: 11715756
    [No Abstract]   [Full Text] [Related]  

  • 11. The lead-based paint abatement repair and maintenance study in Baltimore: historic framework and study design.
    Pollak J
    J Health Care Law Policy; 2002; 6(1):89-108. PubMed ID: 15017953
    [No Abstract]   [Full Text] [Related]  

  • 12. Group benefit and protection of pediatric research subjects: Grimes v. Kennedy Krieger and the Lead Abatement Study.
    Kopelman LM
    Account Res; 2002; 9(3-4):177-92. PubMed ID: 12816126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tarasoff and the researcher: does the duty to protect apply in the research setting?
    Appelbaum PS; Rosenbaum A
    Am Psychol; 1989 Jun; 44(6):885-94. PubMed ID: 11644381
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk and responsibility: ethics, Grimes v Kennedy Krieger, and public health research involving children.
    Mastroianni AC; Kahn JP
    Am J Public Health; 2002 Jul; 92(7):1073-6. PubMed ID: 12084682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The "greater good"...at what cost?: how nontherapeutic scientific studies can now create viable negligence claims in Maryland after Grimes v. Kennedy Krieger Institute, Inc.
    Gray CR
    Univ Baltimore Law Rev; 2002; 32(1):73-95. PubMed ID: 15233132
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of institutional review boards in protecting human subjects: are we really ready to fix a broken system?
    Beh HG
    Law Psychol Rev; 2002; 26(1):1-47. PubMed ID: 16514756
    [No Abstract]   [Full Text] [Related]  

  • 17. The Kennedy Krieger case: judicial anger and the research enterprise.
    Schwartz J
    J Health Care Law Policy; 2002; 6(1):148-68. PubMed ID: 15017955
    [No Abstract]   [Full Text] [Related]  

  • 18. Testing drugs in pediatric populations: the FDA mandate.
    Tauer CA
    Account Res; 1999; 7(1):37-58. PubMed ID: 11657562
    [No Abstract]   [Full Text] [Related]  

  • 19. The standard of disclosure in human subject experimentation.
    Morin K
    J Leg Med; 1998 Jun; 19(2):157-221. PubMed ID: 9658739
    [No Abstract]   [Full Text] [Related]  

  • 20. Liability, regulation and policy in surgical innovation: the cutting edge of research and therapy.
    Mastroianni AC
    Health Matrix Clevel; 2006; 16(2):351-442. PubMed ID: 16948248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.